Each month, we convene several partner organisations from the BEAMER project to discuss one of the six dimensions of quality care—safety, effectiveness, patient-centredness, timeliness, efficiency and equity—as it relates to adherence to treatments. You will learn more about who they are and why they care so much about improving adherence across Europe. You’ll also […]
Each month, we convene several partner organisations from the BEAMER project to discuss one of the six dimensions of quality care—safety, effectiveness, patient-centredness, timeliness, efficiency and equity—as it relates to adherence to treatments. You will learn more about who they are and why they care so much about improving adherence across Europe. You’ll also […]
Each month, we convene several partner organisations from the BEAMER project to discuss one of the six dimensions of quality care—safety, effectiveness, patient-centredness, timeliness, efficiency and equity—as it relates to adherence to treatments. You will learn more about who they are and why they care so much about improving adherence across Europe. You’ll also […]
Each month, we convene several partner organisations from the BEAMER project to discuss one of the six dimensions of quality care—safety, effectiveness, patient-centredness, timeliness, efficiency and equity—as it relates to adherence to treatments. You will learn more about who they are and why they care so much about improving adherence across Europe. You’ll also […]
Each month, we gather a few partner organisations from the BEAMER project to discuss one of the six dimensions of quality care—safety, effectiveness, patient-centredness, timeliness, efficiency, and equity—related to treatment adherence. Today, we’ll speak with patient organisation APDP Diabetes Portugal, full-service recruitment and adherence company Link2Trials, and non-profit organisation UDG Alliance. You’ll learn more about […]
Each month, we gather a few partner organisations from the BEAMER project to discuss one of the six dimensions of quality care—safety, effectiveness, patient-centredness, timeliness, efficiency and equity—as it relates to adherence to treatments. Today, we’ll speak with representatives from patient organisation World Duchenne Organisation, biopharmaceutical company Pfizer and research institution IDIAPJGol. You’ll learn more […]
Join us in our monthly webinars on adherence and non-adherence. You’ll enjoy the pleasure to join International expert panellists as they discuss the most relevant findings and insights related to the topic across various diseases. In our third session, we’ll focus on insights gained across three global projects addressing the health issue: ·Together We […]
Join us in our monthly webinars on adherence and non-adherence. You’ll enjoy the pleasure to join International expert panelists as they discuss the most relevant findings and insights related to the topic across various diseases. In our second session, we’ll focus on the following aspects: · Adherence Levels in Clinical Practice as an Indicator […]
This series kicks off with the first of many monthly webinars on adherence and non-adherence. You’ll enjoy the pleasure to join International expert panelists as they discuss the most relevant findings and insights related to the topic across various diseases. In our first session, we’ll focus on the following aspects: · Non-adherence to Medical Plans […]